Why are Checkpoint Inhibitors Important in Gynecologic Cancers?
Gynecologic cancers, including ovarian, cervical, and endometrial cancers, have shown varying responses to traditional therapies like chemotherapy and radiation. Because of their unique mechanisms, checkpoint inhibitors offer a new avenue for treatment, particularly for patients who have not responded to conventional therapies.
